The emergence of metallo-␤-lactamase (MBL)-producing pathogens is an increasing therapeutic problem. These enzymes have a broad-substrate spectrum; they hydrolyze all ␤-lactams except for the monobactam aztreonam. At the present time, there is no clinically useful inhibitor available. Four distinct types of MBLs-IMP, VIM, SPM, and GIM enzymes-are known in Pseudomonas aeruginosa (3, 5, 9) . Of the VIM MBL, 11 variants have been identified up to the present, constituting three main clusters, represented by VIM-1, VIM-2, and VIM-7 (http://www.lahey.org/Studies/). bla VIM genes are either chromosomally or plasmid located and have been described as parts of the variable region of class 1 integrons (8).
patient seems to be mostly related to the end of the neutropenic episode.
The presence of an MBL was proven using the EDTAphenanthroline-imipenem microdilution test (6) . Repeated attempts to transfer the MBL gene by conjugation, using a rifampin-resistant mutant of Escherichia coli W3110 as the recipient, and filter mating following a previously described method failed (10) . PCR experiments were performed using consensus primers for the detection of bla VIM and bla IMP genes (11) . Additionally, a PCR screening for the SHV, TEM, PSE, OXA-1-, OXA-2-, and OXA-10-group ␤-lactamase genes was conducted. bla SHV , bla TEM , and bla OXA PCRs were carried out as described previously (1, 2, 7). A PCR for the detection of bla PSE was performed with primers PSE-f (5Ј-AA AACAATAGCTTGCGCTAAA-3Ј) and PSE-r (5Ј-TCAGCG CGACTGTGATGTATA-3Ј). Positive results were obtained with the VIM and the PSE primers. To determine the bla VIM and bla PSE variants, the complete genes were sequenced on both strands. The sequences corresponded to bla VIM-2 and bla PSE-1 . The genetic context of the detected bla VIM gene was further investigated by PCR mapping and partial sequencing ( Fig. 1) (4) . These experiments revealed that the detected bla VIM and underline the need for intensified epidemiological surveillance.
